Showing results (141-150 of 195) with videos related to
Sort By:
Pageof 20
Advances in Therapy|October 8, 2021
Determinants of Hyperkalemia Progression Among Patients with Mild HyperkalemiaRubeen Israni, Keith A Betts, Fan Mu, et al.The Journal of Clinical Endocrinology and Metabolism|May 7, 2019
High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart StudyOwen Carmichael, Patrick Stuchlik, Sreekrishna Pillai, et al.The Journal of Clinical Endocrinology and Metabolism|March 15, 2019
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of DiabetesRossana Calderon Moreno, Ana Navas-Acien, Esteban Escolar, et al.Journal of Diabetes and Its Complications|August 1, 2020
Racial and sex differences in the polymorphisms of the endocannabinoid receptor genes in obesityTina K Thethi, Aster Sigel, Shanker Japa, et al.Disaster Medicine and Public Health Preparedness|October 30, 2012
Time to recovery in diabetes and comorbidities following Hurricane KatrinaTina K Thethi, C Lillian Yau, Lizheng Shi, et al.Journal of the Endocrine Society|August 7, 2019
Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal WomenDragana Lovre, Erin Peacock, Bonnie Katalenich, et al.Diabetes Care|October 17, 2013
Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD)Allison B Goldfine, J Stewart Buck, Cyrus Desouza, et al.Journal of Diabetes and Its Complications|October 7, 2014
Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: the EASIE post-hoc analysis and extension trialJuliana C N Chan, Pablo Aschner, David R Owens, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 20, 2017
Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegalyShuqian Liu, Daphne T Adelman, Yaping Xu, et al.Diabetes, Obesity & Metabolism|February 1, 2024
Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial dataTianze Jiao, Hamed Kianmehr, Yilu Lin, et al.Pageof 20